ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding

RNA

Volumn 19, Issue 11, 2013, Pages 1525-1536

  Wang, Qiong ^a,b   Hui, Haipeng ^c   Guo, Zhendong ^a   Zhang, Weina ^a   Hu, Yaou ^a   He, Tao ^a   Tai, Yanhong ^c   Peng, Peng ^a,d   Wang, Li ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

A to I RNA editing; ADARs; ARHGAP26; MicroRNA; MiR 30b 3p; MiR 573

Indexed keywords

ADAR1 PROTEIN; ADENOSINE DEAMINASE; MESSENGER RNA; MICRORNA; MICRORNA 30B 3P; MICRORNA 573; RHO GTPASE ACTIVATING PROTEIN 26; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CATALYSIS; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DISRUPTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; MEDIATOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA BINDING; RNA EDITING;

A-TO-I RNA EDITING; ADARS; ARHGAP26; MICRORNA; MIR-30B-3P; MIR-573;

3' UNTRANSLATED REGIONS; ADENOSINE DEAMINASE; CELL LINE, TUMOR; GTPASE-ACTIVATING PROTEINS; HUMANS; MICRORNAS; NEOPLASMS; RHOA GTP-BINDING PROTEIN; RNA EDITING; RNA, MESSENGER;

EID: 84886060209     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.041533.113     Document Type: Article

References (50)

1. Barresi V, Ragusa A, Fichera M, Musso N, Castiglia L, Rappazzo G, Travali S, Mattina T, Romano C, Cocchi G, et al. 2010. Decreased expression of GRAF1/OPHN-1-L in the X-linked α thalassemia mental retardation syndrome. BMC Med Genomics 3: 28.
2. Bass BL, Weintraub H. 1988. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55: 1089-1098. (Pubitemid 19020061)
3. Bass BL, Nishikura K, Keller W, Seeburg PH, Emeson RB, O'Connell MA, Samuel CE, Herbert A. 1997. A standardized nomenclature for adenosine deaminases that act on RNA. RNA 3: 947-949. (Pubitemid 127641487)
4. Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA, Wooster R, Stratton MR. 2006. RNA editing of human microRNAs. Genome Biol 7: R27.
5. Bojesen SE, Ammerpohl O, Weinhausl A, Haas OA, Mettal H, Bohle RM, Borkhardt A, Fuchs U. 2006. Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome. Br J Cancer 94: 323-332. (Pubitemid 43151555)
6. Borchert GM, Gilmore BL, Spengler RM, Xing Y, Lanier W, Bhattacharya D, Davidson BL. 2009. Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum Mol Genet 18: 4801-4807.
7. Brennecke J, Stark A, Russell RB, Cohen SM. 2005. Principles of microRNA-target recognition. PLoS Biol 3: e85.
8. Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A. 2008. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 283: 7251-7260.
9. Chen LL, Carmichael GG. 2008. Gene regulation by SINES and inosines: Biological consequences of A-to-I editing of Alu element inverted repeats. Cell Cycle 7: 3294-3301.
10. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. 2000. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single-and double-stranded RNA binding domains. RNA 6: 755-767. (Pubitemid 30318470)
11. Desterro JM, Keegan LP, Lafarga M, Berciano MT, O'Connell M, Carmo-Fonseca M. 2003. Dynamic association of RNA-editing enzymes with the nucleolus. J Cell Sci 116: 1805-1818. (Pubitemid 36582167)
12. Doherty GJ, Ahlund MK, Howes MT, Moren B, Parton RG, McMahon HT, Lundmark R. 2011a. The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. Mol Biol Cell 22: 4380-4389.
13. Doherty JT, Lenhart KC, Cameron MV, Mack CP, Conlon FL, Taylor JM. 2011b. Skeletal muscle differentiation and fusion are regulated by the BAR-containing Rho-GTPase-activating protein (Rho-GAP), GRAF1. J Biol Chem 286: 25903-25921.
14. Farajollahi S, Maas S. 2010. Molecular diversity through RNA editing: A balancing act. Trends Genet 26: 221-230.
15. Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco CM, Locatelli F, et al. 2013. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 32: 998-1009.
16. Gallo A, Galardi S. 2008. A-to-I RNA editing and cancer: From pathology to basic science. RNA Biol 5: 135-139.
17. Hildebrand JD, Taylor JM, Parsons JT. 1996. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol 16: 3169-3178. (Pubitemid 26163383)
18. Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, et al. 2002. Blockage of Ca2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8: 971-978. (Pubitemid 35033701)
19. Kallman AM, Sahlin M, Ohman M. 2003. ADAR2 A→I editing: Site selectivity and editing efficiency are separate events. Nucleic Acids Res 31: 4874-4881. (Pubitemid 37441852)
20. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. 2004. Glutamate receptors: RNA editing and death of motor neurons. Nature 427: 801.
21. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. 2007a. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 8: 763-769. (Pubitemid 47202456)
22. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. 2007b. Redirection of silencing targets by adenosineto-inosine editing of miRNAs. Science 315: 1137-1140. (Pubitemid 46328026)
23. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15: 6443-6453.
24. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. 2004. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res 14: 1719-1725. (Pubitemid 39276429)
25. Lehmann KA, Bass BL. 2000. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39: 12875-12884.
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115: 787-798. (Pubitemid 38058492)
27. Liang H, Landweber LF., 2007. Hypothesis: RNA editing of microRNA target sites in humans? RNA 13: 463-467. (Pubitemid 46506929)
28. Lundmark R, Doherty GJ, Howes MT, Cortese K, Vallis Y, Parton RG, McMahon HT. 2008. The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. Curr Biol 18: 1802-1808.
29. Maas S, Patt S, Schrey M, Rich A. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci 98: 14687-14692. (Pubitemid 33121452)
30. Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH. 1996a. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 271: 31795-31798. (Pubitemid 26422196)
31. Melcher T, Maas S, Herb A, Sprengel R, Seeburg PH, Higuchi M. 1996b. A mammalian RNA editing enzyme. Nature 379: 460-464. (Pubitemid 26039528)
32. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. 2006. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217. (Pubitemid 44380294)
33. Miyamura Y, Suzuki T, Kono M, Inagaki K, Ito S, Suzuki N, Tomita Y. 2003. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 73: 693-699. (Pubitemid 37076285)
34. Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
35. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, et al. 2007. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 17: 1586-1595. (Pubitemid 350074854)
36. Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, Zhang MQ, Spector DL. 2005. Regulating gene expression through RNA nuclear retention. Cell 123: 249-263. (Pubitemid 41457215)
37. Qian Z, Lin J, Qian J, Yao DM, Wang YL, Han LX, Zhu ZH, Xiao GF. 2010. [Quantification of GRAF gene expression in patients with acute myeloid leukemia using EvaGreen real time quantitative PCR.] Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27: 290-293.
38. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, et al. 2012. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 44: 1243-1248.
39. Riedmann EM, Schopoff S, Hartner JC, Jantsch MF. 2008. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 14: 1110-1118. (Pubitemid 351717491)
40. Rueter SM, Dawson TR, Emeson RB. 1999. Regulation of alternative splicing by RNA editing. Nature 399: 75-80.
41. Saunders LR, Barber GN. 2003. The dsRNA binding protein family: Critical roles, diverse cellular functions. FASEB J 17: 961-983. (Pubitemid 36676385)
42. Schmauss C. 2005. Regulation of serotonin 2C receptor pre-mRNA editing by serotonin. Int Rev Neurobiol 63: 83-100. (Pubitemid 43631263)
43. Schumacher JM, Lee K, Edelhoff S, Braun RE. 1995. Distribution of Tenr, an RNA-binding protein, in a lattice-like network within the spermatid nucleus in the mouse. Biol Reprod 52: 1274-1283.
44. Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, Cao G, Wang J, Sun Y, Zhang P, Fan M, et al. 2008. Transforming growth factor-β-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 36: 2690-2699. (Pubitemid 351659582)
45. Tang W, Fei Y, Page M. 2012. Biological significance of RNA editing in cells. Mol Biotechnol 52: 91-100.
46. Tariq A, Garncarz W, Handl C, Balik A, Pusch O, Jantsch MF. 2013. RNA-interacting proteins act as site-specific repressors of ADAR2-mediated RNA editing and fluctuate upon neuronal stimulation. Nucleic Acids Res 41: 2581-2593.
47. Wagner RW, Smith JE, Cooperman BS, Nishikura K. 1989. A doublestranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc Natl Acad Sci 86: 2647-2651. (Pubitemid 19112604)
48. Wong SK, Sato S, Lazinski DW. 2001. Substrate recognition by ADAR1 and ADAR2. RNA 7: 846-858. (Pubitemid 32552872)
49. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K. 2006. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 13: 13-21. (Pubitemid 43049397)
50. Zohrabian VM, Nandu H, Gulati N, Khitrov G, Zhao C, Mohan A, Demattia J, Braun A, Das K, Murali R, et al. 2007. Gene expression profiling of metastatic brain cancer. Oncol Rep 18: 321-328.